| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beone Medicines Ltd. (ONC) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. ONC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.58M | $1.45B | - | |
| Pres | 1.45M | $460.10M | - | |
| Dir | 148.1K | $46.94M | - | |
| VP | 97.0K | $30.76M | - | |
| Dir | 64.7K | $20.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | Wang Xiaodong60 | Director, Chair, Scientific Advisory Brd | Sell | 2,007 | $265.50 | $532,867.36 | -45.4% | +26.6% | - | |
| Jun 23, 2025 | Wang Lai52 | Global Head Of R&D | Sell | 1,028 | $260.00 | $267,280.00 | -100% | +31.2% | - | |
| Jun 23, 2025 | Wu Xiaobin54 | President And COO | Sell | 1,363 | $260.00 | $354,380.00 | -100% | +31.2% | - | |
| Jun 23, 2025 | Oyler John60 | Chief Executive Officer | Sell | 3,174 | $261.61 | $830,359.87 | -96.9% | +31.2% | - | |
| Jun 17, 2025 | Wang Lai52 | Global Head Of R&D | Sell | 1,647 | $262.11 | $431,699.06 | -77.8% | +30.8% | - | |
| Jun 17, 2025 | Wu Xiaobin54 | President And COO | Sell | 2,173 | $261.27 | $567,741.71 | -61.5% | +30.8% | - | |
| Jun 17, 2025 | Oyler John60 | Chief Executive Officer | Sell | 5,140 | $263.33 | $1,353,519.55 | -77.9% | +30.8% | - | |
| Jun 16, 2025 | Lee Chan Henry47 | SVP, General Counsel | Sell | 422 | $266.50 | $112,463.00 | -100% | +25.7% | - | |
| Jun 11, 2025 | Ball Titus B. | Principal Accounting Officer | Sell | 134 | $258.36 | $34,620.05 | -100% | +33.8% | - | |
| Jun 10, 2025 | Wang Xiaodong60 | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $262.82 | $10,975,315.61 | -37.8% | +31.5% | - |